The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies.

Autor: Ward JD; University of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, NC, USA. Electronic address: jeremy.ward@unchealth.unc.edu., Cornaby C; Immunology, Histocompatibility and Immunogenetics Laboratories/McLendon Clinical Laboratories UNC Hospitals, Chapel Hill, NC, USA., Kato T; University of North Carolina School of Medicine, Marisco Lung Institute/UNC Cystic Fibrosis Center, Chapel Hill, NC, USA., Gilmore RC; University of North Carolina School of Medicine, Marisco Lung Institute/UNC Cystic Fibrosis Center, Chapel Hill, NC, USA., Bunch D; University of North Carolina School of Medicine, Department of Medicine, Division of Nephrology and Hypertension, Chapel Hill, NC, USA., Miller MB; University of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, NC, USA; Clinical Microbiology and Molecular Microbiology Laboratories, University of North Carolina Health Care, Chapel Hill, NC, USA., Boucher RC; University of North Carolina School of Medicine, Marisco Lung Institute/UNC Cystic Fibrosis Center, Chapel Hill, NC, USA., Schmitz JL; University of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, NC, USA; Immunology, Histocompatibility and Immunogenetics Laboratories/McLendon Clinical Laboratories UNC Hospitals, Chapel Hill, NC, USA., Askin FA; University of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, NC, USA., Scanga LR; University of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, NC, USA. Electronic address: lori.scanga@unchealth.unc.edu.

Publikováno v: Placenta [Placenta] 2022 Jun 01; Vol. 123, pp. 12-23. Date of Electronic Publication: 2022 May 01.